Cantor Fitzgerald began coverage on Oracle Corporation (NYSE:ORCL) stock, giving the tech giant an Overweight rating and ...

Cantor Fitzgerald began its coverage of Snowflake Inc . (NYSE: NYSE:SNOW), assigning an Overweight rating to the company's shares and setting a price target of $201.00. The firm joins 33 other ...

Cantor Fitzgerald initiated coverage of Elastic (ESTC) with a Neutral rating and $108 price target Stay Ahead of the Market:Discover ...

Cantor Fitzgerald initiated coverage of Monday.com (MNDY) with an Overweight rating and $292 price target Stay Ahead of the Market:Discover ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $15.26 which represents a slight increase of $0.44 or 2.97% from the prior close of $14.82. The stock opened at $15.21 ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most substantial contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald reaffirmed their neutral rating on shares of Incyte (NASDAQ:INCY – Free Report) in a report released on Friday morning,Benzinga reports. INCY has been the subject of several other ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...